I'm certainly no expert on this topic and forgive me if this has already been discussed... Genuine question: I presume that Recce 327 never been introduced inside a living human. If/when that happens, I don't understand how it will not eventually kill any normal healthy body. We need to produce our good bacteria in order to live. Essential helpers for breaking down food and disposing of many toxins and especially break down our own old/used cells. So if these 327 "critters" can go on forever in a body, destroying every bacteria and perhaps other bacteria-like particles, then eventually it'd be a death sentence, correct? Give it a year or two. In vitro means so little when something as complex as the human body is the real money. I guess we'll find out pretty soon, because these days (eg. in the US and UK) there seems to be no shortage of people volunteering themselves for experimental drugs.
- Forums
- ASX - By Stock
- RCE
- Ann: Positive Data on RECCE 327 Against All Six ESKAPE Pathogens
RCE
recce pharmaceuticals ltd
Add to My Watchlist
1.67%
!
29.5¢

Ann: Positive Data on RECCE 327 Against All Six ESKAPE Pathogens, page-30
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $85.06M |
Open | High | Low | Value | Volume |
29.5¢ | 29.5¢ | 29.0¢ | $38.76K | 133.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 135000 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 9819 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 135000 | 0.285 |
9 | 289506 | 0.280 |
3 | 34419 | 0.275 |
4 | 24814 | 0.270 |
1 | 5000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 9819 | 2 |
0.300 | 2050 | 1 |
0.330 | 114230 | 1 |
0.350 | 31739 | 3 |
0.375 | 8002 | 1 |
Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |